Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Prof. Aldo Stroebel serves on SAYAS
2011-09-23

 

Prof. Aldo Stroebel


Prof. Aldo Stroebel, from our university, has been elected as a Founding Member of the South African Young Academy of Science (SAYAS).
 
He is currently Associate Professor in the Centre for Sustainable Agriculture, Rural Development and Extension, as well as the Director of International Academic Programmes in the Office of the Vice-Chancellor at the university.
 
The Young Academy has as its objectives to represent young scientists in advising the government on science and technology policy and human resource development. In addition, they will prepare the SAYAS to join the Global Young Academy (GYA) to engage with high-level international bodies, including the World Economic Forum. Twenty Founding Members have been elected – ten new members will be elected annually to a maximum of 50.
 
Prof. Stroebel obtained his master’s degree at the University of Ghent, in Belgium, and a PhD at the UFS after a year of graduate coursework at Cornell University in the USA. He completed post-doctoral work at Wageningen University and Research Centre in The Netherlands, where he has been appointed as a Visiting Fellow to their recently-established Centre for Food Security and Sustainable Development. He has published widely, including more than 90 journal articles, book chapters and reports, and co-edited a book published by CTA Wageningen. He has supervised ten master's and doctoral students.  
 
He serves in various capacities: he is a member of the Research and Innovation Strategy Group of Higher Education South Africa (HESA), former member of the SANPAD Board, the President of the International Network of Research Management Societies (INORMS) Conference in 2010, and Vice-President of Research and President-elect of the Southern African Research and Innovation Management Association (SARIMA).
 
Prof. Stroebel has participated in a number of national and international conferences. He was a keynote speaker at the Society of Research Administrators (SRA) in Washington DC in the USA and at the Ministerial Conference on Higher Education in Agriculture in Uganda.
 
He has worked as a consultant and/or advisor for a number of international and multinational organisations, including the Food and Agricultural Organisation of the United Nations (FAO), the United States Agency for International Development (USAID), World Bank, Lux Development, and the World Conservation Union (IUCN), Switzerland.
  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept